Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...

Embecta, a company that develops diabetes management solutions, is moving into the auto-injection market with its latest planned acquisition. The Becton Dickinson & CO spinoff reported it would ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

For developers using AI, “vibe coding” right now comes down to babysitting every action or risking letting the model run unchecked. Anthropic says its latest update to Claude aims to eliminate that ...

Kroger said it is now stocking Eli Lilly's injection pen version of the weight-loss drug Zepbound, and will allow self-pay customers to use Lilly's savings card at its retail pharmacies. The ...

Eli Lilly (NYSE: LLY) stock tumbled 5% through noon ET Tuesday. You can blame investment bank HSBC for that. HSBC, you see, just downgraded Lilly stock to sell. Will AI create the world's first ...

March 23 (Reuters) - At least half a dozen Indian generic drugmakers launched cheaper versions of Novo Nordisk's (NOVOb.CO), opens new tab blockbuster diabetes drug Ozempic and weight‑loss drug Wegovy ...

A woman has slammed a Birmingham pharmacy after buying 'fake' Mounjaro pens to aid her ongoing weight loss. The 46-year-old woman, who has asked not to be named, has been injecting herself with the ...

Zepbound (tirzepatide) is a prescription drug used for weight loss and obstructive sleep apnea in certain adults. It works by reducing appetite and slowing digestion, which makes you consume fewer ...